Recent Developments in the Genetic and Genomic Basis of Type 2 Diabetes

被引:0
|
作者
Richards H.B. [1 ,2 ]
McCarthy M.I. [1 ,3 ,4 ]
机构
[1] Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 7LJ, Churchill Hospital, Old Road, Headington
[2] MRC Harwell, Mammalian Genetics Unit, Harwell Science and Innovation Campus, Oxfordshire
[3] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, Roosevelt Drive
[4] Oxford NIHR Biomedical Research Centre, Oxford, OX3 7LJ, Churchill Hospital, Old Road, Headington
关键词
Cardiovascular disease; Complex traits; Genetic association; Genome-wide association studies; Heritability; Hyperglycaemia; Type; 2; diabetes;
D O I
10.1007/s12170-012-0281-x
中图分类号
学科分类号
摘要
Genome wide association studies (GWAS) have transformed the study of heritable factors influencing complex diseases such as type 2 diabetes (T2D), with the current tally of established risk loci approaching 70. Each of these loci has the potential to offer novel insights into the biology of this disease, and opportunities for clinical exploitation. However, the complexity of this condition has often frustrated efforts to achieve these functional and translational advances. This review describes progress made over the past year to expand genome wide association studies, to characterize the mechanisms through which diabetes risk loci operate, and to define the processes involved in diabetes predisposition. © 2012 Springer Science+Business Media New York.
引用
收藏
页码:66 / 72
页数:6
相关论文
共 50 条
  • [31] Genetic Risk Factors of Macrovascular Complications in Patients With Type 2 Diabetes
    Bystrova, A. A.
    Ulitina, A. S.
    Kim, M. V.
    Skoryukova, S. A.
    Miroshnikova, V. V.
    Panteleeva, A. A.
    Korelskaya, N. A.
    He, Zhu
    Nikolaev, M. A.
    Pchelina, S. N.
    Baranova, E. I.
    Krasilnikova, E. I.
    KARDIOLOGIYA, 2017, 57 (02) : 17 - 22
  • [32] Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology
    Mollon, Josephine
    Curran, Joanne E.
    Mathias, Samuel R.
    Knowles, Emma E. M.
    Carlisle, Phoebe
    Fox, Peter T.
    Olvera, Rene L.
    Goring, Harald H. H.
    Rodrigue, Amanda
    Almasy, Laura
    Duggirala, Ravi
    Blangero, John
    Glahn, David C.
    DIABETOLOGIA, 2020, 63 (05) : 977 - 986
  • [33] Genetic predisposition to obesity leads to increased risk of type 2 diabetes
    Li, S.
    Zhao, J. H.
    Luan, J.
    Langenberg, C.
    Luben, R. N.
    Khaw, K. T.
    Wareham, N. J.
    Loos, R. J. F.
    DIABETOLOGIA, 2011, 54 (04) : 776 - 782
  • [34] Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the diabetes heart study
    Adams, Jeremy N.
    Cox, Amanda J.
    Freedman, Barry I.
    Langefeld, Carl D.
    Carr, J. Jeffrey
    Bowden, Donald W.
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [35] Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus
    Defossa, Elisabeth
    Wagner, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 2991 - 3000
  • [36] A network analysis framework of genetic and nongenetic risks for type 2 diabetes
    Zhang, Yuan
    Li, Shu
    Cao, Zhi
    Cheng, Yangyang
    Xu, Chenjie
    Yang, Hongxi
    Sun, Li
    Jiao, Hongxiao
    Wang, Ju
    Li, Wei-Dong
    Wang, Yaogang
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (02) : 461 - 469
  • [37] Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update
    Usman, Bashir
    Sharma, Neha
    Satija, Saurabh
    Mehta, Meenu
    Vyas, Manish
    Khatik, Gopal L.
    Khurana, Navneet
    Hansbro, Philip M.
    Williams, Kylie
    Dua, Kamal
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (23) : 2510 - 2525
  • [38] Aetiopathology and genetic basis of neonatal diabetes
    Shield, JPH
    Gardner, RJ
    Wadsworth, EJK
    Whiteford, ML
    James, RS
    Robinson, DO
    Baum, JD
    Temple, IK
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 76 (01): : F39 - F42
  • [39] Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes
    Ma, R. C. W.
    So, W. Y.
    Tam, C. H. T.
    Luk, A. O.
    Ho, J. S. K.
    Wang, Y.
    Lam, V. K.
    Lee, H. M.
    Kong, A. P.
    Tong, P. C.
    Xu, G.
    Chow, C. C.
    Ng, M. C.
    Yang, X. L.
    Chan, J. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) : 328 - 337
  • [40] Validating the doubly weighted genetic risk score for the prediction of type 2 diabetes in the Lifelines and Estonian Biobank cohorts
    Parna, Katri
    Snieder, Harold
    Lall, Kristi
    Fischer, Krista
    Nolte, Ilja
    GENETIC EPIDEMIOLOGY, 2020, 44 (06) : 589 - 600